Dr. Jitendra Singh, Union Minister of State (Independent Charge) for Science & Technology, described the Union Budget as a blueprint for sustained progress, with affordable drugs and local biomanufacturing set to benefit middle and underprivileged groups profoundly.
In his media address, the minister highlighted the budget’s sequential vision, integrating structural changes with AI-enhanced technologies. It opts for long-term relief—lowering health and living costs—over fleeting gains, reassuring the middle class.
He detailed how biopharma investments will lighten loads for chronic disease sufferers. India’s 11-12 crore diabetics, 14 crore pre-diabetics, and escalating cancer (expected 20 lakh cases/year by 2030) stand to gain immensely from vaccines, diagnostics, and gene therapies.
Building on India’s global bio-hub status, the Rs 10,000 crore push expands capacities in critical areas, rivaling IT’s transformative legacy. A bio-revolution looms, featuring regenerative tech and circular models.
The budget innovates by prioritizing mental health and non-communicable diseases, announcing North India super-specialty institutes and new centers for Ayurveda and pharma education. This fusion of tradition and modernity ensures inclusive, advanced healthcare nationwide.